Henry Schein (NASDAQ:HSIC) rose 7.4% amid a report that an activist investor has taken a stake and is pushing for the dental ...

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office ... small and large equipment repair services, branded and generic ...

"We believe we continued to steadily gain market share in our dental and medical distribution businesses following last year's cyber incident. Our dental equipment business is showing ongoing ...

Dental products distributor Henry Schein beat third-quarter profit estimates on Tuesday, as a series of cost-saving measures helped counter tepid demand and slow recovery from a cyberattack it ...

Analyst Erin Wright of Morgan Stanley maintained a Sell rating on Henry Schein (HSIC – Research Report), retaining the price target of ...

Henry Schein is a Fortune 500 company and one of the global leaders in its industry, providing healthcare solutions, as well ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.5, a high estimate of $82.00, ...

The dental supplies firm raised the lower end of its 2024 adjusted earnings projection, and now anticipates a range between $4.74 and $4.82 a share, compared with the prior $4.70-to-$4.82 a share ...

Henry Schein ( (HSIC) ) has released its Q3 earnings. Here is a breakdown of the information Henry Schein presented to its investors. Henry ...